QuidelOrtho Corporation (QDEL) Balance Sheet

The balance sheet has contracted by roughly $1.0B in assets and $1.5B in equity over ten quarters, driven by persistent net losses and a $500M increase in total debt. This trajectory suggests the company is consuming its capital base to fund operations, with no immediate reversal in sight. The deterioration is consistent with the prior income statement analysis showing nine consecutive quarters of net losses.

The D/E ratio has more than doubled, reflecting both higher debt and shrinking equity. This leverage appears strategic in the context of the Ortho acquisition, but the sustained cash burn and negative operating margins raise concerns about the company's ability to service this debt from internal cash flows. Investors should monitor refinancing risk, especially if interest rates remain elevated.

The dramatic increase in goodwill likely stems from the Ortho acquisition, but the subsequent impairment in Q3 2025 (as noted in prior analysis) suggests that the carrying value may still be at risk. The stable PPE suggests limited new investment in tangible assets, which could hinder the company's ability to support future growth. The asset mix now leans heavily on intangibles, increasing the risk of further write-downs if expected synergies fail to materialize.

The erosion of retained earnings underscores the severity of the company's profitability problems. With no dividends and minimal buybacks, the equity decline is entirely attributable to operational losses and impairments. This suggests that the company is not generating sufficient returns to sustain its capital base, and further dilution or asset sales may be necessary to shore up equity.

The current ratio remains above 1, but the trend is concerning given the negative operating cash flow and the need to service debt. With cash levels below $150M and a quarterly cash burn that has exceeded $100M in some periods, the company may face liquidity constraints if it cannot improve working capital management or secure additional financing. The decline in deferred revenue from $50.1M to $35.4M also suggests a softening in advance payments, which could pressure near-term cash flows.